EpiPharma Therapeutics Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
EpiPharma Therapeutics General Information
Description
Developer of an investigational drug intended for the treatment of eosinophilic esophagitis.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
- Victoria, British Columbia
- Canada
Primary Industry
Drug Discovery
Acquirer
Corporate Office
- Victoria, British Columbia
- Canada
EpiPharma Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
EpiPharma Therapeutics FAQs
-
Where is EpiPharma Therapeutics headquartered?
EpiPharma Therapeutics is headquartered in Victoria, Canada.
-
What industry is EpiPharma Therapeutics in?
EpiPharma Therapeutics’s primary industry is Drug Discovery.
-
Is EpiPharma Therapeutics a private or public company?
EpiPharma Therapeutics is a Private company.
-
What is EpiPharma Therapeutics’s current revenue?
The current revenue for EpiPharma Therapeutics is .
-
When was EpiPharma Therapeutics acquired?
EpiPharma Therapeutics was acquired on 01-Jan-2023.
-
Who acquired EpiPharma Therapeutics?
EpiPharma Therapeutics was acquired by Eupraxia Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process